A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Clinical trial NCT07121244 · TERMINATED

Trial details

NCT number: NCT07121244
Sponsor: Radionetics Oncology
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Locoregionally Recurrent Hormone-receptor Positive Breast Cancer Metastatic Hormone Receptor Positive Breast Cancer

Start date: 2025-10-01
Primary completion: 2026-06-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.